Clinical Trials

New Search
Title   Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
Disease/Condition   Gastrointestinal Cancer,Head and Neck Cancer,Oncology (Medical/Hematologic),Radiation Oncology,Oral Mucositis
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Rafi Kabarriti, MD
Contact Name   Alyssa Asaro
Contact Email
IRB/Protocol Number   18-06-208-01
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   Radiation Oncologyl